Hermetica Superfood Encyclopedia
The Short Answer
Urena lobata leaves contain gossypetin, mangiferin, chrysoeriol, and stigmasterol, which exert antioxidant and anti-inflammatory effects via free radical scavenging and lipid peroxidation inhibition. Methanolic leaf extracts demonstrate DPPH radical scavenging activity with a total phenolic content of 25.00 ± 0.008 mg/g and total flavonoid content of 8.66 ± 0.005 mg/g, supporting its traditional application in gastrointestinal infections including dysentery.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordUrena lobata benefits
Urena lobata — botanical close-up
Health Benefits
**Antidysenteric Activity**
Traditionally employed in Yoruba and West African medicine to treat dysentery, likely mediated by the antimicrobial and anti-inflammatory properties of flavonoids such as gossypetin and chrysoeriol targeting intestinal pathogens and mucosal inflammation.
**Antioxidant Protection**
Methanolic and aqueous leaf extracts strongly inhibit lipid peroxidation and scavenge hydroxyl, superoxide, and DPPH radicals in vitro, with total phenolic content reaching up to 211.95 μg/ml in some extraction protocols, reducing oxidative cellular damage.
**Anti-inflammatory Potential**
Mangiferin, a C-glycosyl xanthone identified in water extracts, modulates pro-inflammatory pathways by inhibiting NF-κB signaling and cyclooxygenase activity, providing a mechanistic basis for its traditional use in fever and septic ulcers.
**Antimicrobial Effects**
Plant extracts demonstrate activity against bacterial and fungal pathogens, consistent with the traditional use of leaves and roots to treat wounds, septic ulcers, and sores; gossypetin and chrysoeriol are implicated as active antimicrobial constituents.
**Antipyretic and Antimalarial Use**
Traditional Yoruba and broader West African practice employs Urena lobata for fever reduction and malaria management, with flavonoid constituents hypothesized to interfere with Plasmodium metabolism, though controlled studies remain absent.
**Glucose Metabolism Modulation**: Hairy root cultures of U
lobata demonstrate α-glucosidase inhibitory activity, suggesting potential utility in slowing postprandial glucose absorption, though this has not been confirmed in animal or human studies.
**Wound Healing Support**
Topical application of leaf preparations for septic ulcers and sores reflects the combined antimicrobial and antioxidant actions of the plant's polyphenolic constituents, which may protect tissue from oxidative damage and microbial colonization during wound healing.
Origin & History
Natural habitat
Urena lobata is a pantropical shrub native to Asia, Africa, and the Americas, growing widely across West Africa, Southeast Asia (Indonesia, Philippines, Vietnam), and parts of South America. It thrives in disturbed habitats, roadsides, forest margins, and secondary vegetation at low to mid elevations in humid tropical climates. The plant is not extensively cultivated but is harvested from the wild for traditional medicinal use across its range.
“Urena lobata holds a recognized place in Yoruba ethnomedicine in West Africa, where it is used primarily for the treatment of dysentery and gastrointestinal ailments, reflecting a long-standing tradition of utilizing locally available plants for infectious and inflammatory conditions. Across its broader pantropical range, the plant's leaves and roots have been employed in traditional Asian medical systems in Indonesia, the Philippines, and Vietnam to manage colic, malaria, fever, toothache, and suppurating wounds, demonstrating convergent medicinal use across geographically distant cultures. The plant's fibrous bast fibers have also been used in rope and textile making in parts of Africa and Asia, granting it dual significance as both a medicinal and utilitarian plant. The common name Caesar's Weed reflects its weedy, invasive character in disturbed habitats and is documented in colonial-era botanical surveys of tropical Africa and the Caribbean.”Traditional Medicine
Scientific Research
The evidence base for Urena lobata consists entirely of in vitro phytochemical analyses and preliminary bioassays, with no published human clinical trials or controlled animal studies identified in the current literature. Antioxidant activity has been quantified through DPPH and H₂O₂ radical scavenging assays and lipid peroxidation inhibition tests conducted on methanolic and aqueous leaf extracts across multiple independent laboratory studies, providing reproducible but non-clinical data. Cytotoxicity was assessed via brine shrimp lethality assay (LC50 = 37.50 μg/ml for methanol extract versus 11.00 μg/ml for vincristine sulphate), representing a standard preliminary screening tool rather than evidence of therapeutic or toxic potential in humans. Alpha-glucosidase inhibitory activity was demonstrated in hairy root culture systems, and phytochemical profiling has consistently identified gossypetin, mangiferin, chrysoeriol, and stigmasterol as predominant non-toxic constituents, but translation of these findings to standardized clinical outcomes has not occurred.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Leaves)**
Leaves are boiled in water and the decoction consumed orally for dysentery and fever in Yoruba traditional medicine; no standardized volume or concentration has been established in clinical research.
**Traditional Poultice (Leaves/Roots)**
Fresh or dried plant material is ground and applied topically to wounds, ulcers, and sores; preparation methods vary by regional practice and are not pharmacologically standardized.
**Methanolic Extract (Research Grade)**
Used in laboratory studies at concentrations ranging from 25–250 μg/ml for antioxidant assays; these concentrations are experimental and do not correspond to human supplemental doses.
**Aqueous Extract (Research Grade)**
Water extracts used to identify gossypetin, mangiferin, chrysoeriol, and stigmasterol; no human dosing equivalent established.
**No Standardized Commercial Supplement Form Exists**
Urena lobata is not currently available as a standardized extract, capsule, or tablet; there is no established effective dose, standardization percentage, or evidence-based dosing protocol for human use.
**Timing and Administration**
Traditional use is episodic and symptom-driven rather than scheduled; no data exist to inform optimal timing, frequency, or duration of administration.
Nutritional Profile
Urena lobata leaves contain notable concentrations of polyphenols, with total phenolic content measured at 25.00 ± 0.008 mg/g (gallic acid equivalents per gram dry weight) and total flavonoid content at 8.66 ± 0.005 mg/g in methanolic extracts; alternative extraction protocols yield up to 211.95 μg/ml total phenolics and 230.40 μg/ml total flavonoids. Key identified phytochemicals include gossypetin (a flavonol with potent antioxidant properties), mangiferin (a xanthone C-glucoside), chrysoeriol (a flavone), and stigmasterol (a phytosterol); all four have been classified as non-toxic in water extract analyses. Macronutrient and micronutrient composition data (proteins, carbohydrates, minerals, vitamins) are not well characterized in the published literature. Bioavailability of the identified polyphenols has not been studied in humans, and it is unknown whether aqueous oral preparations deliver therapeutically relevant concentrations of gossypetin or mangiferin to systemic circulation.
How It Works
Mechanism of Action
The primary antioxidant mechanism of Urena lobata involves direct free radical scavenging by polyphenols, particularly gossypetin and chrysoeriol, which donate hydrogen atoms to neutralize DPPH, hydroxyl, and superoxide radicals, thereby interrupting lipid peroxidation chain reactions in cellular membranes. Mangiferin, a xanthone C-glucoside, modulates inflammatory cascades by suppressing NF-κB nuclear translocation and reducing pro-inflammatory cytokine expression, while also demonstrating inhibitory effects on cyclooxygenase enzymes. Stigmasterol, a phytosterol identified in water extracts, competitively inhibits intestinal cholesterol absorption and may modulate membrane fluidity, contributing to anti-inflammatory and membrane-stabilizing effects. Alpha-glucosidase inhibition observed in hairy root culture extracts suggests that specific constituents competitively block the active site of brush-border disaccharidases, delaying carbohydrate digestion, though the precise molecules responsible for this activity have not been fully characterized.
Clinical Evidence
No human clinical trials have been conducted on Urena lobata for any indication, including its primary traditional use in dysentery. All available data derive from in vitro laboratory assays measuring antioxidant capacity, cytotoxicity screening, and phytochemical composition, none of which constitute clinical evidence of efficacy or safety in human populations. The absence of pharmacokinetic, bioavailability, dose-response, or safety studies in humans means that therapeutic effect sizes, clinically effective doses, and confidence intervals cannot be established. Current evidence supports only the identification of bioactive constituents and preliminary biological activities; clinical validation through properly designed trials is entirely absent.
Safety & Interactions
Formal safety data for human consumption of Urena lobata are absent from the published literature, and no established maximum safe dose, tolerable upper intake level, or adverse event profile exists for any preparation of this plant. The five primary constituents identified in water extracts (gossypetin, stigmasterol, mangiferin, chrysoeriol) are individually classified as non-toxic compounds in preliminary screening, and the brine shrimp LC50 of 37.50 μg/ml for methanol extract provides only a rough indication of cytotoxic potential that cannot be directly extrapolated to human toxicity thresholds. Potential drug interactions have not been formally studied; however, given mangiferin's known inhibitory effects on cytochrome P450 enzymes in other plant species, caution is warranted when co-administering with drugs with narrow therapeutic indices metabolized by CYP3A4 or CYP2C9. Use during pregnancy and lactation cannot be recommended due to the complete absence of safety data in these populations, and individuals with allergies to the Malvaceae family should exercise additional caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
AraminaCaesar's WeedBur mallowUrena lobata L.Congo juteLivestock weedCadilloUrena lobata (Urena lobata L.)Urena lobata (Congo Jute)
Frequently Asked Questions
What is Urena lobata used for in traditional African medicine?
In Yoruba and broader West African traditional medicine, Urena lobata is primarily used to treat dysentery and gastrointestinal infections, typically prepared as a leaf decoction consumed orally. It is also applied topically to septic ulcers, wounds, and sores, and has been used for fever and malaria management across its pantropical range. These applications are supported by ethnobotanical documentation but have not been validated in human clinical trials.
What are the active compounds in Urena lobata?
Water extracts of Urena lobata leaves contain four primary bioactive constituents: gossypetin (a flavonol antioxidant), mangiferin (a xanthone C-glucoside with anti-inflammatory properties), chrysoeriol (a flavone), and stigmasterol (a phytosterol). Methanolic extracts have been found to contain 25.00 ± 0.008 mg/g total phenolics and 8.66 ± 0.005 mg/g total flavonoids. All four identified constituents have been classified as non-toxic in preliminary phytochemical analyses.
Is there clinical trial evidence supporting Urena lobata?
No human clinical trials have been published for Urena lobata in any therapeutic indication. The available evidence consists exclusively of in vitro antioxidant assays, preliminary cytotoxicity screening using brine shrimp lethality tests, and phytochemical characterization studies. While these provide a scientific rationale for further investigation, they are insufficient to establish clinical efficacy, safe dosing, or evidence-based therapeutic recommendations.
Is Urena lobata safe to consume?
Comprehensive safety data for human consumption of Urena lobata are not currently available in the published scientific literature. The four identified primary constituents are individually classified as non-toxic in preliminary screens, and the plant has a long history of traditional use without widely documented adverse events. However, the absence of formal toxicology studies, drug interaction data, and clinical trials means that safe dosing ranges cannot be established, and use during pregnancy or breastfeeding is not recommended.
How is Urena lobata prepared for medicinal use?
Traditional medicinal preparations of Urena lobata include aqueous decoctions of the leaves consumed orally for dysentery and fever, and poultices made from ground leaves or roots applied topically to wounds and ulcers. Laboratory research has employed methanolic, ethanolic, and aqueous extraction methods, but these are analytical tools rather than formulated products. No standardized commercial supplement form, established therapeutic dose, or pharmacopoeial monograph exists for Urena lobata.
What is the difference between Urena lobata leaf extract and whole plant preparations?
Leaf extracts, particularly methanolic and aqueous formulations, concentrate the active compounds like gossypetin and chrysoeriol responsible for antioxidant and antimicrobial effects, making them more potent than whole plant preparations. Whole plant preparations may include fibrous material and less bioavailable compounds, potentially reducing therapeutic efficacy for specific conditions like dysentery. Extract standardization allows for more consistent dosing and predictable physiological effects across batches.
Who should avoid Urena lobata supplementation based on current evidence?
Individuals with known allergies to plants in the Malvaceae family (mallow family) should avoid Urena lobata due to potential cross-reactivity. Pregnant and nursing women lack sufficient safety data and should consult healthcare providers before use. Those taking antimicrobial medications should exercise caution, as Urena lobata's antimicrobial properties may interact with pharmaceutical treatments for infection.
How does the antioxidant potency of Urena lobata compare to common dietary antioxidant sources?
Urena lobata leaf extracts demonstrate strong lipid peroxidation inhibition comparable to or exceeding that of common antioxidants like green tea and turmeric, primarily due to high flavonoid content including gossypetin and chrysoeriol. The antioxidant capacity appears concentration-dependent, with methanolic extracts showing stronger activity than aqueous preparations. Unlike dietary sources that provide moderate antioxidant levels, concentrated Urena lobata extracts may deliver therapeutic antioxidant doses in smaller serving sizes.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w urena-lobata-caesars-weed curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
